Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Chest|July 16, 2011
Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease managementShelley Shapiro, Glenna L Traiger, Michelle Turner, et al.
Mayo Clinic Proceedings|August 14, 2012
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®Natalie Kitterman, Abby Poms, Dave P Miller, et al.
The American Journal of Cardiology|November 2, 2013
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry)Robyn J Barst, D Dunbar Ivy, Aimee J Foreman, et al.
The American Journal of Cardiology|October 30, 2010
Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settingsD Dunbar Ivy, Erika Berman Rosenzweig, Jean-Christophe Lemarié, et al.
Circulation|March 19, 2014
STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertensionRobyn J Barst, Maurice Beghetti, Tomas Pulido, et al.
Journal of the American College of Cardiology|June 15, 2004
Diagnosis and differential assessment of pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Adam Torbicki, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentanRaymond L Benza, Sanjay Mehta, Anne Keogh, et al.
British Journal of Haematology|July 1, 2009
Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three yearsMargaret T Lee, Tania Small, Muhammad A Khan, et al.
Transplantation|June 19, 2010
Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL RegistryRaymond L Benza, Dave P Miller, Adaani Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 20, 2013
One-year experience with intravenous treprostinil for pulmonary arterial hypertensionRaymond L Benza, Victor F Tapson, Mardi Gomberg-Maitland, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Chest|July 16, 2011
Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease managementShelley Shapiro, Glenna L Traiger, Michelle Turner, et al.
Mayo Clinic Proceedings|August 14, 2012
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®Natalie Kitterman, Abby Poms, Dave P Miller, et al.
The American Journal of Cardiology|November 2, 2013
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry)Robyn J Barst, D Dunbar Ivy, Aimee J Foreman, et al.
The American Journal of Cardiology|October 30, 2010
Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settingsD Dunbar Ivy, Erika Berman Rosenzweig, Jean-Christophe Lemarié, et al.
Circulation|March 19, 2014
STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertensionRobyn J Barst, Maurice Beghetti, Tomas Pulido, et al.
Journal of the American College of Cardiology|June 15, 2004
Diagnosis and differential assessment of pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Adam Torbicki, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentanRaymond L Benza, Sanjay Mehta, Anne Keogh, et al.
British Journal of Haematology|July 1, 2009
Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three yearsMargaret T Lee, Tania Small, Muhammad A Khan, et al.
Transplantation|June 19, 2010
Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL RegistryRaymond L Benza, Dave P Miller, Adaani Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 20, 2013
One-year experience with intravenous treprostinil for pulmonary arterial hypertensionRaymond L Benza, Victor F Tapson, Mardi Gomberg-Maitland, et al.
Pageof 14